Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study

Maud Rothärmel, Cherifa Benosman, Wissam El-Hage, Wissam El-Hage, Caroline Berjamin, Diane Ribayrol, Olivier Guillin, Olivier Guillin, Olivier Guillin, Raphaël Gaillard, Lucie Berkovitch, Lucie Berkovitch, Virginie Moulier, Virginie Moulier

Open source

DOI: 10.3389/fpsyt.2022.865466
Published: 7
Container: Frontiers in Psychiatry
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fpsyt.2022.865466,
  title = {Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study},
  author = {Maud Rothärmel and Cherifa Benosman and Wissam El-Hage and Wissam El-Hage and Caroline Berjamin and Diane Ribayrol and Olivier Guillin and Olivier Guillin and Olivier Guillin and Raphaël Gaillard and Lucie Berkovitch and Lucie Berkovitch and Virginie Moulier and Virginie Moulier},
  year = {2022},
  journal = {Frontiers in Psychiatry},
  doi = {10.3389/fpsyt.2022.865466},
  url = {https://doi.org/10.3389/fpsyt.2022.865466}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study
AU  - Maud Rothärmel
AU  - Cherifa Benosman
AU  - Wissam El-Hage
AU  - Wissam El-Hage
AU  - Caroline Berjamin
AU  - Diane Ribayrol
AU  - Olivier Guillin
AU  - Olivier Guillin
AU  - Olivier Guillin
AU  - Raphaël Gaillard
AU  - Lucie Berkovitch
AU  - Lucie Berkovitch
AU  - Virginie Moulier
AU  - Virginie Moulier
PY  - 2022
JO  - Frontiers in Psychiatry
DO  - 10.3389/fpsyt.2022.865466
UR  - https://doi.org/10.3389/fpsyt.2022.865466
ER  -

APA

Rothärmel, M., Benosman, C., El-Hage, W., El-Hage, W., Berjamin, C., Ribayrol, D., Guillin, O., Guillin, O., Guillin, O., Gaillard, R., Berkovitch, L., Berkovitch, L., Moulier, V., & Moulier, V. (2022). Efficacy and Safety of Intranasal Esketamine in Patients With Treatment-Resistant Depression and Comorbid Chronic Post-traumatic Stress Disorder: Open-Label Single-Arm Pilot Study. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.865466

Source records

doaj · retrieved 2026-09-26T13:27:09.066Z